NO134299B - - Google Patents
Download PDFInfo
- Publication number
- NO134299B NO134299B NO534/72A NO53472A NO134299B NO 134299 B NO134299 B NO 134299B NO 534/72 A NO534/72 A NO 534/72A NO 53472 A NO53472 A NO 53472A NO 134299 B NO134299 B NO 134299B
- Authority
- NO
- Norway
- Prior art keywords
- formula
- phthalazone
- group
- compound
- same meaning
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 56
- -1 carbamoyl- Chemical group 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 36
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 150000001412 amines Chemical class 0.000 claims description 17
- IJAPPYDYQCXOEF-UHFFFAOYSA-N phthalazin-1(2H)-one Chemical class C1=CC=C2C(=O)NN=CC2=C1 IJAPPYDYQCXOEF-UHFFFAOYSA-N 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 229910021529 ammonia Inorganic materials 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 9
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 6
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 6
- 125000003944 tolyl group Chemical group 0.000 claims description 5
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical group CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 150000002429 hydrazines Chemical class 0.000 claims description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000005110 aryl thio group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 54
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 238000002844 melting Methods 0.000 description 22
- 230000008018 melting Effects 0.000 description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 239000011541 reaction mixture Substances 0.000 description 15
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 13
- 150000002513 isocyanates Chemical class 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000012948 isocyanate Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 5
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical class NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 150000003512 tertiary amines Chemical class 0.000 description 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002026 chloroform extract Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 2
- NYXHSRNBKJIQQG-UHFFFAOYSA-N methyl n-methylcarbamate Chemical compound CNC(=O)OC NYXHSRNBKJIQQG-UHFFFAOYSA-N 0.000 description 2
- SCWKRWCUMCMVPW-UHFFFAOYSA-N phenyl n-methylcarbamate Chemical compound CNC(=O)OC1=CC=CC=C1 SCWKRWCUMCMVPW-UHFFFAOYSA-N 0.000 description 2
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 2
- 229940067157 phenylhydrazine Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- MGAXYKDBRBNWKT-UHFFFAOYSA-N (5-oxooxolan-2-yl)methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1OC(=O)CC1 MGAXYKDBRBNWKT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- LHYKTQVFLKHQSR-UHFFFAOYSA-N 1-amino-3-methylurea Chemical compound CNC(=O)NN LHYKTQVFLKHQSR-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- PGLFGNJUOPLFLV-UHFFFAOYSA-N 3-amino-1,1-dimethylurea Chemical compound CN(C)C(=O)NN PGLFGNJUOPLFLV-UHFFFAOYSA-N 0.000 description 1
- HXUIDZOMTRMIOE-UHFFFAOYSA-N 3-oxo-3-phenylpropionic acid Chemical compound OC(=O)CC(=O)C1=CC=CC=C1 HXUIDZOMTRMIOE-UHFFFAOYSA-N 0.000 description 1
- ICGLPKIVTVWCFT-UHFFFAOYSA-N 4-methylbenzenesulfonohydrazide Chemical compound CC1=CC=C(S(=O)(=O)NN)C=C1 ICGLPKIVTVWCFT-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 1
- 125000005118 N-alkylcarbamoyl group Chemical group 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ISKQADXMHQSTHK-UHFFFAOYSA-N [4-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=C(CN)C=C1 ISKQADXMHQSTHK-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 125000005236 alkanoylamino group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- VJRITMATACIYAF-UHFFFAOYSA-N benzenesulfonohydrazide Chemical compound NNS(=O)(=O)C1=CC=CC=C1 VJRITMATACIYAF-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- JGFBRKRYDCGYKD-UHFFFAOYSA-N dibutyl(oxo)tin Chemical compound CCCC[Sn](=O)CCCC JGFBRKRYDCGYKD-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- WNVQCJNZEDLILP-UHFFFAOYSA-N dimethyl(oxo)tin Chemical compound C[Sn](C)=O WNVQCJNZEDLILP-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- GCFHZZWXZLABBL-UHFFFAOYSA-N ethanol;hexane Chemical compound CCO.CCCCCC GCFHZZWXZLABBL-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- WHRIKZCFRVTHJH-UHFFFAOYSA-N ethylhydrazine Chemical compound CCNN WHRIKZCFRVTHJH-UHFFFAOYSA-N 0.000 description 1
- 125000002425 furfuryl group Chemical group C(C1=CC=CO1)* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Chemical class 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- FRPUZPKXFMJGKF-UHFFFAOYSA-N isochromene-1,4-dione Chemical compound C1=CC=C2C(=O)COC(=O)C2=C1 FRPUZPKXFMJGKF-UHFFFAOYSA-N 0.000 description 1
- VKHZYWVEBNIRLX-UHFFFAOYSA-N methanesulfonohydrazide Chemical compound CS(=O)(=O)NN VKHZYWVEBNIRLX-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- SELYJABLPLKXOY-UHFFFAOYSA-N methyl n,n-dimethylcarbamate Chemical compound COC(=O)N(C)C SELYJABLPLKXOY-UHFFFAOYSA-N 0.000 description 1
- PWFYXEJZPCACLT-UHFFFAOYSA-N methyl n-propan-2-ylcarbamate Chemical compound COC(=O)NC(C)C PWFYXEJZPCACLT-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- PJLHXSBKGRJXHA-UHFFFAOYSA-N n-ethylcarbamoyl chloride Chemical compound CCNC(Cl)=O PJLHXSBKGRJXHA-UHFFFAOYSA-N 0.000 description 1
- GRRYSIXDUIAUGY-UHFFFAOYSA-N n-methylcarbamoyl chloride Chemical compound CNC(Cl)=O GRRYSIXDUIAUGY-UHFFFAOYSA-N 0.000 description 1
- YSBUANSGDLZTKV-UHFFFAOYSA-N n-phenylcarbamoyl chloride Chemical compound ClC(=O)NC1=CC=CC=C1 YSBUANSGDLZTKV-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- VJZNUICECYWOFV-UHFFFAOYSA-N o-phenyl carbamothioate Chemical compound NC(=S)OC1=CC=CC=C1 VJZNUICECYWOFV-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- BSCCSDNZEIHXOK-UHFFFAOYSA-N phenyl carbamate Chemical compound NC(=O)OC1=CC=CC=C1 BSCCSDNZEIHXOK-UHFFFAOYSA-N 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- NPQONXIVTPCTNX-UHFFFAOYSA-N s-phenyl n-methylcarbamothioate Chemical compound CNC(=O)SC1=CC=CC=C1 NPQONXIVTPCTNX-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical class 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
- A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Nærværende oppfinnelse vedrorer en fremgangsmåte til fremstilling av nye 4-karbamoksymetyl-l-ftalazon-derivater med den generelle formel The present invention relates to a process for the production of new 4-carbamoxymethyl-1-phthalazone derivatives with the general formula
hvor R betyr et hydrogenatom eller en lavere alkylgruppe, spesielt C i - Co, alkylgruppe: betyr et ledd utvalgt fra gruppen bestående av et hydrogenatom, en lavere alkylgruppe som kan være forgrenet eller en cyklisk lavere alkylgruppe, en alkenylgruppe, spesielt - alkenylgruppe, fenyl eller tolylgruppe, benzyl eller fenetyl, en di-lavere-alkylamino-lavere alkylgruppe, fortrinnsvis C - C,- alkylgruppe med C^- where R means a hydrogen atom or a lower alkyl group, especially C i - Co, alkyl group: means a member selected from the group consisting of a hydrogen atom, a lower alkyl group which may be branched or a cyclic lower alkyl group, an alkenyl group, especially - alkenyl group, phenyl or tolyl group, benzyl or phenethyl, a di-lower-alkylamino-lower alkyl group, preferably C - C 1 - alkyl group with C 1 -
eller C2-alkylaminogrupper, en furfurylgruppe, en piko-lylgruppe og en pyridylgruppe$ or C 2 alkylamino groups, a furfuryl group, a picolyl group and a pyridyl group
R^ betyr et ledd utvalgt fra gruppen bestående av et hydrogenatom, en lavere alkylgruppe, spesielt C, - alkylgruppe, fenyl- eller tolylgruppe, en karbamoylgruppe, en N-lavere-alkylkarbamoylgruppe, fortrinnsvis en N-alkylkarbamoylgruppe med C - alkylgruppe, en K.N-di-lavere-alkylkarbamoylgruppe, fortrinnsvis en N.N-dialkylkarba-moylgruppe med CL - C 3 alkylgrupper, en lavere alkyl-sulfonylgruppe, spesielt med C^- C lavere alkylgruppe og en fenylsulfonyl- eller tolylsulfonylgruppe^R^ means a member selected from the group consisting of a hydrogen atom, a lower alkyl group, especially C, - alkyl group, phenyl or tolyl group, a carbamoyl group, an N-lower alkylcarbamoyl group, preferably an N-alkylcarbamoyl group with C - alkyl group, a K.N -di-lower-alkylcarbamoyl group, preferably an N.N-dialkylcarbamoyl group with C1-C3 alkyl groups, a lower alkyl-sulfonyl group, especially with C1-C lower alkyl group and a phenylsulfonyl or tolylsulfonyl group
R4 betyr et hydrogenatom, et halogenatom såsom Cl, Br, R4 means a hydrogen atom, a halogen atom such as Cl, Br,
I eller F, fortrinnsvis Cl eller Br, en lavere alkylgruppe, spesielt C.^ - C3 alkylgruppe og en lavere alkoksygruppe, fortrinnsvis C - C4 alkoksygruppe5I or F, preferably Cl or Br, a lower alkyl group, in particular a C 1 - C 3 alkyl group and a lower alkoxy group, preferably a C - C 4 alkoxy group5
R5 betyre et hydrogenatom, et halogenatom, såsom Cl, Br, I eller F, fortrinnsvis Cl eller Br, en.lavere alkylgruppe, spesielt C^ - C3 alkylgruppe, en alkoksygruppe, fortrinnsvis C^ - C^ alkoksygruppe, en aminogruppe, en lavere alkanoylaminogruppe, en lavere alkoksykarbonylgruppe, fortrinnsvis en alkoksykarbonylgruppe med C^ - C^ alkoksygruppe og en karbamoylgruppe, og R.j og R 2 kan sammen med karbamoylgruppens nitrogenatom danne en pyrrolidin-, piperidin-, morfolin- eller 4-metyl-piperazingruppe, og R5 means a hydrogen atom, a halogen atom, such as Cl, Br, I or F, preferably Cl or Br, a lower alkyl group, especially a C₁ - C₃ alkyl group, an alkoxy group, preferably a C₁ - C₃ alkoxy group, an amino group, a lower alkanoylamino group, a lower alkoxycarbonyl group, preferably an alkoxycarbonyl group with a C₁ - C₁ alkoxy group and a carbamoyl group, and R.j and R.sup.2 can together with the nitrogen atom of the carbamoyl group form a pyrrolidine, piperidine, morpholine or 4-methyl-piperazine group, and
R^ og R^ kan være tilstede i enhver av C-5-, C-6-, C-7 eller C-8-stillingene av ftalazonkjernen. R 1 and R 2 may be present at any of the C-5, C-6, C-7 or C-8 positions of the phthalazone ring.
Ovenstående forbindelser kan fremstilles ved hjelp av en hvilken som helst av de folgende fremgangsmåter: The above compounds can be prepared by any of the following methods:
a) en forbindelse med den generelle formel a) a compound with the general formula
hvor R^, R4 og R^ har samme betydning som i formel where R^, R4 and R^ have the same meaning as in formula
(I), (IN),
får reagere med et isocyanat med formel is allowed to react with an isocyanate of formula
hvor R2 har samme betydning som i formel (I) med unntagelse for et hydrogenatom. where R 2 has the same meaning as in formula (I) with the exception of a hydrogen atom.
eller or
b) forbindelsen med den generelle formel (II) omdannes ved hjelp av kjente metoder til en forbindelse med den generelle b) the compound with the general formula (II) is converted using known methods into a compound with the general formula
formel formula
hvor . R^ og R^ har samme betydning som angitt under formel (I), og hvor where . R^ and R^ have the same meaning as stated under formula (I), and where
X betyr et oksygen- eller svovel-atom, X means an oxygen or sulfur atom,
Z betyr en lavere alkylgruppe eller en arylgruppe Z means a lower alkyl group or an aryl group
som kan substitueres, which can be substituted,
og hvorefter forbindelser med formel (IV) får reagere med ammoniakk eller et amin med formel and then compounds of formula (IV) are allowed to react with ammonia or an amine of formula
hvor R^ og R_ har den samme betydning som angitt where R^ and R_ have the same meaning as indicated
i formel (I) , in formula (I),
eller or
c) forbindelsen med formel (II) får reagere med fosgen, hvorefter den intermediære forbindelse med formel c) the compound of formula (II) is allowed to react with phosgene, after which the intermediate compound of formula
hvor , R^ og R^ har samme betydning som angitt i formel (I), where , R^ and R^ have the same meaning as stated in formula (I),
får reagere med ammoniakk eller aminet med formel (V), eller may react with ammonia or the amine of formula (V), or
d) forbindelsen med formel (II) får reagere med et derivat d) the compound of formula (II) is allowed to react with a derivative
■iav en karbaminsyre med formel ■iav a carbamic acid of formula
hvor R-^ og R^ har samme betydning som angitt i formel (I) , og where R-^ and R^ have the same meaning as stated in formula (I), and
Y betyr et halogenatom, en alkoksy-, aryloksy-, Y means a halogen atom, an alkoxy-, aryloxy-,
alkyltio- eller aryltio-gruppe, alkylthio or arylthio group,
eller or
e) en forbindelse med den generelle formel e) a compound with the general formula
hvor R^, R^, R^ og R^ har samme betydning som where R^, R^, R^ and R^ have the same meaning as
angitt i formel (I), given in formula (I),
får reagere med et hydrazinderivat med formel is allowed to react with a hydrazine derivative of formula
hvor R^ har samme betydning som angitt i formel (I). where R^ has the same meaning as stated in formula (I).
Forbindelser ifolge nærværende oppfinnelse kan fremstilles ved hjelp av en hvilken som helst oven beskrevet fremgangsmåte. Compounds according to the present invention can be prepared using any of the methods described above.
De ved hjelp av oven beskrevne fremgangsmåter fremstilte forbindelser er nye, og i den eksperimentelle atherosclerosis forårsaket av tilfort kolesterol viser de en dyptgående effekt med hensyn til å forebygge atherosclerosis ved å The compounds prepared by means of the methods described above are new, and in the experimental atherosclerosis caused by added cholesterol they show a profound effect with respect to preventing atherosclerosis by
inhibere av-setning av kolesterol på arterieveggene„ De forebygger også okningen av koaguleringsevnen og henfallenhet for thrombose som forårsakes av innsproytningsbehandling av dyr med kolesterol eller adrenalin, dvs. at de forebygger forkortning av storkningstiden for blod såvel som forhoyning av adenosindifosfat-forårsaket blodplate-aggregering hos dyr. Forbindelsene ifolge oppfinnelsen er anvendelig for behandling inhibiting the deposition of cholesterol on the arterial walls. They also prevent the increase in coagulation ability and susceptibility to thrombosis caused by injection treatment of animals with cholesterol or adrenaline, i.e. they prevent the shortening of blood clotting time as well as the increase in adenosine diphosphate-induced platelet aggregation in animals. The compounds according to the invention are useful for treatment
av atherosclerotiske og thrombose-sykdommer. of atherosclerotic and thrombotic diseases.
Utgangsmaterialet ifolge oppfinnelsen, og som har formel (II), The starting material according to the invention, and which has formula (II),
kan fremstilles enten ved hjelp av kjente metoder eller ved hjelp av de.i det folgende beskrevne nye metodene. can be produced either by means of known methods or by means of the new methods described below.
1) 4-hydroksymetyl-l-ftalazon kan fremstilles fra 2-karboksy-acetofenon ved nedenstående beskrevne reaksjons-sekvens. Denne fremgangsmåte beskrives i Ber. 40, 72 (190 7) og Annual Report of Department of Pharmacy, Kanazawa University, Vol. 12, 1-6 (1961). 2) Ovenstående beskrevne metode 1) kan ikke anvendes for de substituerte ftalazon-derivatene på grunn av at utgangsmaterialene vanligvis er utilgjengelige. Vi har nå funnet at en forbindelse med formel 1) 4-Hydroxymethyl-1-phthalazone can be produced from 2-carboxy-acetophenone by the reaction sequence described below. This procedure is described in Ber. 40, 72 (1907) and Annual Report of the Department of Pharmacy, Kanazawa University, Vol. 12, 1-6 (1961). 2) The above described method 1) cannot be used for the substituted phthalazone derivatives due to the fact that the starting materials are usually unavailable. We have now found that a connection with formula
hvor R^, R4 og R,, har samme betydning som angitt i formel (I), og hvor where R 1 , R 4 and R 1 have the same meaning as stated in formula (I), and where
Y' betyr en alkoksygruppe eller et halogenatom, Y' means an alkoxy group or a halogen atom,
kan lett reduseres til forbindelsen med formel (II) med natrium-borhydrid. (sml. japansk patentansokning nr. 58643/71). Forbindelser med formel (X) kan fremstilles ved hjelp av kjente metoder, f.eks. metoden som er beskrevet i J. of Am. Chem. Soc, 68, 1316 (1946). can be easily reduced to the compound of formula (II) with sodium borohydride. (comp. Japanese patent application no. 58643/71). Compounds of formula (X) can be prepared using known methods, e.g. the method described in J. of Am. Chem. Soc, 68, 1316 (1946).
3) Vi har også funnet at forbindelsen med formel (II) kan fremstilles ved å la en forbindelse med formel 3) We have also found that the compound of formula (II) can be prepared by adding a compound of formula
hvor R. og R,- har samme betydning som angitt i where R. and R,- have the same meaning as stated in
formel (I), formula (I),
reagere med hydrazinderivater med formel (IX). Forbindelser med formel (XI) kan fremstilles ved hjelp av en i Ber. 40, 72 (1907) beskrevet ar /.-log måte eller ved hjelp av folgende reaksj onsskj ema. react with hydrazine derivatives of formula (IX). Compounds of formula (XI) can be prepared using a Ber. 40, 72 (1907) described ar /.-log way or by means of the following reaction scheme.
Fremgangsmåten for forbindelsen (XI) til forbindelsen (II) kan anskueliggjores ved hjelp av folgende skjema. The procedure for compound (XI) to compound (II) can be visualized using the following scheme.
Denne metode er spesielt anvendelig for fremstilling av ftalazon-forbindelser som er substituerte ved N-2-stillingen i. ftalazon-kj ernen. This method is particularly applicable for the production of phthalazone compounds which are substituted at the N-2 position in the phthalazone nucleus.
Eksempler på forbindelser med formel (II) omfatter 4-hyd.roksy-metyl-l-ftalazon, 4-hydroksymetyl-2-metyl-l-ftalazon, 2-etyl-4-hydroksymetyl-l-ftalazon, 4-hydroksymetyl-2-fenyl-l-ftalazon, 4-hydroksymetyl-2-tolyl-l-ftalazon, 2-karbamoyl-4-hydroksymetyl-l-ftalazon? 4-hydroksymetyl-2- (N-metyl-karbamoyl)-1-ftalazon, 2-(N,N-dimetyl-karbamoyl)-4-hydroksymetyl-l-ftalazon, 4-hydroksymetyl-2-metylsulfonyl-l-ftalazon, 2-benzensulfonyl-4-hydroksymetyl-l-ftalazon, og 4-hydroksymetyl-2- (p-toluensul-fonyl)-1-ftalazon. Ytterligere, 4-hydroksymetyl-l-ftaliizon-derivater som har en eller to substituenter såsom kloratom, Examples of compounds of formula (II) include 4-hydroxymethyl-1-phthalazone, 4-hydroxymethyl-2-methyl-1-phthalazone, 2-ethyl-4-hydroxymethyl-1-phthalazone, 4-hydroxymethyl-2 -phenyl-l-phthalazone, 4-hydroxymethyl-2-tolyl-l-phthalazone, 2-carbamoyl-4-hydroxymethyl-l-phthalazone? 4-hydroxymethyl-2-(N-methyl-carbamoyl)-1-phthalazone, 2-(N,N-dimethyl-carbamoyl)-4-hydroxymethyl-l-phthalazone, 4-hydroxymethyl-2-methylsulfonyl-l-phthalazone, 2-benzenesulfonyl-4-hydroxymethyl-1-phthalazone, and 4-hydroxymethyl-2-(p-toluenesulfonyl)-1-phthalazone. Furthermore, 4-hydroxymethyl-1-phthaliizone derivatives having one or two substituents such as chlorine atom,
et bromatom, en alkyl-, alkoksy-, amin-, acetylamino-, alkoksykarbonyl- og karbamoyl-gruppe i enhver av C-5-,'C-6-, C-7- og C-8-stillingene i ftalazon-kjernen, kan også anvendes. F.eks. 7-klor-4-hydroksymetyl-l-ftalazon, 7-brom-4-hydroksymetyl-1-ftalazon, 4-hydroksymetyl-7-metoksy-2-metyl-l-ftalazon, 4-hydroksymetyl-7-metoksy-2-f enyl-l-f talazon, 5-acetylamiiio-4-hydroksymetyl-l-ftalazon, 8-acetylamino-4-hydroksymetyl-7-metoksy-l-ftalazon, 7-etoksykarbonyl-4-hydroksymetyl-l-ftalazon, 8-amino-7-klor-4-hydroksymetyl-l-ftalazon, 6,7-dimetyl-4-hydroksymetyl-l-ftalazon, 4-hydroksymetyl-2,6,7-trimetyl-l-ftalazon, 7-klor-4-hydroksymetyl-2- (N-metylkarbamoyl)-1-ftalazon, 2-benzensulfonyl-4-hydroksymetyl-7-metoksy-l-ftalazon, og 7-brom-4-hydroksymetyl-2- (p-toluensulfonyl)-1-ftalazon kan nevnes. a bromine atom, an alkyl, alkoxy, amine, acetylamino, alkoxycarbonyl and carbamoyl group at any of the C-5, C-6, C-7 and C-8 positions of the phthalazone nucleus , can also be used. E.g. 7-chloro-4-hydroxymethyl-l-phthalazone, 7-bromo-4-hydroxymethyl-1-phthalazone, 4-hydroxymethyl-7-methoxy-2-methyl-l-phthalazone, 4-hydroxymethyl-7-methoxy-2- phenyl-l-phthalazone, 5-acetylamino-4-hydroxymethyl-l-phthalazone, 8-acetylamino-4-hydroxymethyl-7-methoxy-l-phthalazone, 7-ethoxycarbonyl-4-hydroxymethyl-l-phthalazone, 8-amino- 7-chloro-4-hydroxymethyl-l-phthalazone, 6,7-dimethyl-4-hydroxymethyl-l-phthalazone, 4-hydroxymethyl-2,6,7-trimethyl-l-phthalazone, 7-chloro-4-hydroxymethyl- 2-(N-methylcarbamoyl)-1-phthalazone, 2-benzenesulfonyl-4-hydroxymethyl-7-methoxy-1-phthalazone, and 7-bromo-4-hydroxymethyl-2-(p-toluenesulfonyl)-1-phthalazone may be mentioned .
Ifolge fremgangsmåte e) kan utgangsmaterialene (VIII) fremstilles av tidligere beskrevne forbindelser med formel (XI) ifolge folgende skjema. According to method e), the starting materials (VIII) can be prepared from previously described compounds with formula (XI) according to the following scheme.
Som eksempel på forbindelsen (VIII) kan nevnes, tu-karbamoksy-2-karbamoylacetofenon, 2-(N-metylkarbamoksy)-2-karbamoyl-acetofenon, tu- (N,N-dimetylkarbamoksy)-2-karbamoyl-acetofenon, uj- (N ,N-tetrametylenkarbamoksy)-2-karbamoylacetofenon, og æ- (N,N-pentametylenkarbamoksy)-2-karbamoylacetofenon. As an example of the compound (VIII) can be mentioned, tu-carbamoxy-2-carbamoylacetophenone, 2-(N-methylcarbamoxy)-2-carbamoyl-acetophenone, tu-(N,N-dimethylcarbamoxy)-2-carbamoyl-acetophenone, uj- (N,N-tetramethylenecarbamoxy)-2-carbamoylacetophenone, and ε-(N,N-pentamethylenecarbamoxy)-2-carbamoylacetophenone.
Videre kan oven beskrevne acetofenon-derivater, som har en eller to substituenter representert ved R. eller R^ i formel (I) i en av C-3-, C-4-, C-5- eller C-6-stillingene i ftalazon-kjernene kan også anvendes. Furthermore, the acetophenone derivatives described above, which have one or two substituents represented by R. or R.sub.3 in formula (I) in one of the C-3, C-4, C-5 or C-6 positions in the phthalazone cores can also be used.
Ved utforelsesformen ifolge fremgangsmåte a) for forbindelsen (I) reagere med en ekvimolar mengde eller et overskudd, spesielt mellom 1,2 og 2 mol, isocyanat (II) i et inert losningsmiddel eller fortynningsmiddel, såsom benzen, toluen, klor-benzen, acetonitril, kloroform, dioksan, tetrahydrofuran eller pyridin. Reaksjonen foretas ved en temperatur mellom romtemperatur og 150°c, spesielt under 100°C. Ved en temperatur mellom 50 - 100°c vil reaksjonen vanligvis være fullfort på 1 - 5 timer. Ved ca. romtemperatur foretrekkes lengre reaksjonstid, f.eks. mellom 5 og 24 timer. Hvis nodvendig kan en katalysator, såsom tertiært amin, f.eks. trimetylamin, trietylamin, et N-alkylpiperidin eller pyridin anvendes. In the embodiment according to method a) for the compound (I) react with an equimolar amount or an excess, especially between 1.2 and 2 mol, of isocyanate (II) in an inert solvent or diluent, such as benzene, toluene, chlorobenzene, acetonitrile , chloroform, dioxane, tetrahydrofuran or pyridine. The reaction is carried out at a temperature between room temperature and 150°C, especially below 100°C. At a temperature between 50 - 100°c, the reaction will usually be complete in 1 - 5 hours. At approx. room temperature, longer reaction time is preferred, e.g. between 5 and 24 hours. If necessary, a catalyst, such as tertiary amine, e.g. trimethylamine, triethylamine, an N-alkyl piperidine or pyridine are used.
Eksempler på isocyanatet (III) omfatter metyl-, etyl-, propyl-, isopropyl-, butyl-, amyl-, cykloheksyl-, allyl-, fenyl-, tolyl-, xylyl-, |3-dimetylaminoetyl-, y-dietylaminopropyl-, a- og (3-furfuryl-, a-, (3- og y-pikolyl-, a-, |3- og y-pyridylisocyanat. Examples of the isocyanate (III) include methyl-, ethyl-, propyl-, isopropyl-, butyl-, amyl-, cyclohexyl-, allyl-, phenyl-, tolyl-, xylyl-, |3-dimethylaminoethyl-, y-diethylaminopropyl- , α- and (3-furfuryl-, α-, (3- and γ-picolyl-, α-, β- and γ-pyridyl isocyanate.
I stedet for isocyanatet (III), så kan man anvende forbindelser som kan omdannes til isocyanatet med formel (III) unde;r reaksjonsbetingelsene, og hvis nodvendig kan en katalysator som danner isocyanat in situ anvendes. F.eks. kan acylazid med formel Instead of the isocyanate (III), compounds can be used which can be converted into the isocyanate of formula (III) under the reaction conditions, and if necessary, a catalyst which forms isocyanate in situ can be used. E.g. can acylazide with formula
hvor R har samme betydning aom i formel (I), where R has the same meaning as in formula (I),
bortsett fra et hydrogenatom, except for one hydrogen atom,
eller S-alkyltiolkarbamater representert ved formel or S-alkyl thiol carbamates represented by formula
hvor R2 har samme betydning som angitt i formel (I), med unntagelse for et hydrogenatom, og hvor "alkyl" betyr en lavere alkylgruppe såsom metyl-eller etyl-gruppe, where R 2 has the same meaning as stated in formula (I), with the exception of a hydrogen atom, and where "alkyl" means a lower alkyl group such as a methyl or ethyl group,
anvendes med oppvarming. S-alkyl-thiokarbamater kan også anvendes i nærvær av et trialkylamin og et tungmetallsalt, used with heating. S-alkyl thiocarbamates can also be used in the presence of a trialkylamine and a heavy metal salt,
såsom solvnitrat. such as solvate nitrate.
I overensstemmelse med reaksjonen ifolge nærværende oppfinnelse av forbindelsen med formel (II) med forbindelsen med formel (III), så omfatter reaksjonen også reaksjonen av forbindelsen (II) med en forbindelse som kan omdannes til forbindelsen med formel (III) under reaksjonsbetingelsene. Fremgangsmåten a) kan bare anvendes for tilvirkning av forbindelser hvor R^ betyr et hydrogenatom og hvor R2 ikke betyr hydrogenatom. In accordance with the reaction according to the present invention of the compound of formula (II) with the compound of formula (III), the reaction also includes the reaction of the compound (II) with a compound which can be converted into the compound of formula (III) under the reaction conditions. Method a) can only be used for the production of compounds where R 1 means a hydrogen atom and where R 2 does not mean a hydrogen atom.
Ved utfdrelsesformen ifolge fremgangsmåte b) blir en forbindelse med formel (II) omdannet til en forbindelse med formel In the derivative form according to method b), a compound of formula (II) is converted into a compound of formula
(IV) ved kjente metoder med en ester av klorkarbon eller klor-tiolkarbonsyre representert ved formelen (IV) by known methods with an ester of chlorocarbon or chloro-thiolcarbonic acid represented by the formula
hvor X og z har samme betydning som angitt i formel where X and z have the same meaning as stated in formula
(IV) . (IV).
Ved denne fremgangsmåten foretrekkes 4-fenoksykarbonyloksymetyl-1-ftalazon-derivater, hvor X og Z betyr hhv. et oksygenatom og en fenylgruppe i formel (IV) på grunn av okonomiske hensyn samt produktets tilgjengelighet. I stedet for fenylgruppen kan man også anvende den substituerte fenylgruppen, f.eks. p-klorfenyl- og p-nitrofenyl-gruppen, samt a- og (3-naftyl-gruppen. Andre ftalazonderivater, såsom 4-alkoksykarbonyloksy-metyl-l-ftalazon, 4-alkyltiokarbonyloksymetyl-l-ftalazon og 4-aryltiokarbonyloksymetyl-l-ftalazon-derivater kan anvendes hvis nodvendig. Eksempler på forbindelser med formel (IV) In this method, 4-phenoxycarbonyloxymethyl-1-phthalazone derivatives are preferred, where X and Z mean respectively an oxygen atom and a phenyl group in formula (IV) due to economic considerations as well as the availability of the product. Instead of the phenyl group, one can also use the substituted phenyl group, e.g. the p-chlorophenyl and p-nitrophenyl group, as well as the a- and (3-naphthyl group. Other phthalazone derivatives, such as 4-alkylthiocarbonyloxymethyl-l-phthalazone, 4-alkylthiocarbonyloxymethyl-l-phthalazone and 4-arylthiocarbonyloxymethyl-l- phthalazone derivatives can be used if necessary Examples of compounds of formula (IV)
er 4-metoksykarbonyloksymetyl-l-ftalazon, 4-fenoksy-karbonyloksy-metyl-l-ftalazon, 4- (p-klorfenoksy-karbonyloksyletyl)-1- is 4-methoxycarbonyloxymethyl-l-phthalazone, 4-phenoxy-carbonyloxy-methyl-l-phthalazone, 4-(p-chlorophenoxy-carbonyloxyethyl)-1-
ftalazon, 4-metyltiokarbonyloksymetyl-l-ftalazon, 4-etyltio-karbonyloksymetyl-l-ftalazon og 4-fenyltiokarbonyloksymetyl-1-ftalazon. Videre kan også de oven beskrevne ftalazonderivatene anvendes, ogsom har en eller to substituenter representert ved R4 eller R5 i formel (I) i en av C-5-, C-6-, C-7-, og C-8-stillingene i ftalazon-kjernene og/eller substituenten representert ved R^ i formel (I) i N-2 i ftalazon-kjernene. phthalazone, 4-methylthiocarbonyloxymethyl-1-phthalazone, 4-ethylthiocarbonyloxymethyl-1-phthalazone and 4-phenylthiocarbonyloxymethyl-1-phthalazone. Furthermore, the phthalazone derivatives described above can also be used, and which have one or two substituents represented by R4 or R5 in formula (I) in one of the C-5, C-6, C-7 and C-8 positions in the phthalazone nuclei and/or the substituent represented by R 1 in formula (I) in N-2 of the phthalazone nuclei.
Forbindelsen med formel (IV) får derefter reagere med ammoniakk eller et amin med formel (V). Fremgangsmåten b) kan anskueliggjores ved hjelp av folgende reaksjonsskjerna: The compound of formula (IV) is then allowed to react with ammonia or an amine of formula (V). Procedure b) can be visualized using the following reaction core:
Reaksjonen av forbindelsen *IV) med aminet kan utfores i The reaction of the compound *IV) with the amine can be carried out in
nærvær eller fravær av losningsmidler eller fortynningsmidler, f.eks. metanol, etanol og propanol. Generelt forloper reaksjonen lett ved en temperatur mellom 0° og 100°C, selv ved ca. romtemperatur, og er fullfort innen noen timer. Airmoniakker, eller aminet kan anvendes i overskudd, og vanligvis er en mengde på 1 -, 10 mol amin pr. mol forbindelse (IV) tilfreds-stillende. Eksempler på amiri med formel (V) er primære aminer, såsom metyl-, etyl-, propyl-, isopropyl-, butyl-, amyl-, allyl-, cykloheksyl-, benzyl-, (3-dimetylaminoetyl-, y-dietylaminopropyl-, pikolyl-, og furfurylaniin, og sekundære aminer såsom dimetylamin, dietylamin, pyrrolidin, piperidin, N-metylpiperazin og morfolin. presence or absence of solvents or diluents, e.g. methanol, ethanol and propanol. In general, the reaction proceeds easily at a temperature between 0° and 100°C, even at approx. room temperature, and is complete within a few hours. Air ammonia, or the amine can be used in excess, and usually an amount of 1 - 10 mol of amine per moles of compound (IV) satisfactorily. Examples of amines of formula (V) are primary amines, such as methyl-, ethyl-, propyl-, isopropyl-, butyl-, amyl-, allyl-, cyclohexyl-, benzyl-, (3-dimethylaminoethyl-, γ-diethylaminopropyl- , picolyl-, and furfurylaniine, and secondary amines such as dimethylamine, diethylamine, pyrrolidine, piperidine, N-methylpiperazine and morpholine.
Ved utforelsesformen ifolge fremgangsmåte c) omdannes en forbindelse med formel (II) til en ester av klorkarbonsyren med formel (VI) ved reaksjon med fosgen. Derefter får det intermediære produktet med formel (VI) reagere med ammoniakk eller et amin med formel (IV). Fremgangsmåten b) kan gjengis ved hjelp av folgende reaksjonsskjema: In the embodiment according to method c), a compound of formula (II) is converted into an ester of the chlorocarbonic acid of formula (VI) by reaction with phosgene. The intermediate product of formula (VI) is then allowed to react with ammonia or an amine of formula (IV). Procedure b) can be reproduced using the following reaction scheme:
Fremgangsmåten c) kan utfores i to uavhengige trinn, nemlig The method c) can be carried out in two independent steps, viz
ved reaksjon med fosgen og ved reaksjon med amin. Da det intermediære produktet (VI) er ustabilt og vanskelig å rengjore, så foretrekkes det å utfore, fremgangsmåten i ett trinn uten isolering av produktet (VI). Med utforelsesformen ifolge fremgangsmåte b) opploses eller suspenderes en forbindelse med formel (II) i et inert løsningsmiddel eller fortynningsmiddel. såsom et aromatisk hydrokarbon, eter, og klorert hydrokarbon. Eksempler på løsningsmiddel eller fortynningsmiddel er benzen, toluen, xylen, etyleter, dioksan, kloroform og etylen- by reaction with phosgene and by reaction with amine. As the intermediate product (VI) is unstable and difficult to purify, it is preferred to carry out the process in one step without isolating the product (VI). With the embodiment according to method b), a compound of formula (II) is dissolved or suspended in an inert solvent or diluent. such as an aromatic hydrocarbon, ether, and chlorinated hydrocarbon. Examples of solvents or diluents are benzene, toluene, xylene, ethyl ether, dioxane, chloroform and ethylene-
diklorid eller deres blandinger. Til losningen eller sus-pensjonen tilsettes fortrinnsvis et tertiært amin, såsom di- dichloride or their mixtures. A tertiary amine is preferably added to the solution or suspension, such as di-
metylanilin, dietylanilin, trietylamin, N-alkylpiperidin og pyridin som et dehydroklorerende middel eller katalysator. methylaniline, diethylaniline, triethylamine, N-alkylpiperidine and pyridine as a dehydrochlorinating agent or catalyst.
Som vist i ovenstående reaksjonsskjerna fremstilles to mol klorhydrogensyre, og det er derfor nodvendig å anvende minst As shown in the above reaction core, two moles of hydrochloric acid are produced, and it is therefore necessary to use at least
to mol tertiært amin. I reaksjonen med amin er det mulig å erstatte det tertiære aminet med reaktantaminet. Mengden fosgen er vanligvis mellom 1,0 - 1,2 mol pr. mol ftalazon, two moles of tertiary amine. In the reaction with amine, it is possible to replace the tertiary amine with the reactant amine. The amount of phosgene is usually between 1.0 - 1.2 mol per mol phthalazone,
men anvendt overskudd av amin (V) hindrer ikke reaksjonen. Reaksjonen utfores ved en temperatur mellom -10 - 10°C, but excess of amine (V) used does not prevent the reaction. The reaction is carried out at a temperature between -10 - 10°C,
og er fullfort på 1 - 20 timer. and is completed in 1 - 20 hours.
Ved utforelsen av fremgangsmåten d) får forbindelsen (II) reagere med en ekvimolar mengde eller et overskudd, spesielt mellom 1,5 - 5 mol, av forbindelsen (VII) i et inert løsnings-middel i fravær eller nærvær av en katalysator. Da derivatene av karbaminsyre representeres ved formel (VII) så kan man anvende ikke-substituert, eller N-monosubstituert eller N.N-disubstituert karbamylklorid, alkylkarbamat, arylkarbamat, alkyltiolkarbamat, og aryltiolkarbamat. F.eks. kan man nevne karbamylklorid, og da som karbamylklorid metylkarbamylklorid, etylkarbamylklorid, dimetylkarbamylklorid, N,N-pentametylen-karbamylklorid og fenylkarbamylklorid; et alkylkarbamat, In carrying out method d), the compound (II) is allowed to react with an equimolar amount or an excess, especially between 1.5 - 5 mol, of the compound (VII) in an inert solvent in the absence or presence of a catalyst. As the derivatives of carbamic acid are represented by formula (VII), unsubstituted, or N-monosubstituted or N.N-disubstituted carbamyl chloride, alkyl carbamate, aryl carbamate, alkyl thiol carbamate, and aryl thiol carbamate can be used. E.g. one can mention carbamyl chloride, and then as carbamyl chloride methylcarbamyl chloride, ethylcarbamyl chloride, dimethylcarbamyl chloride, N,N-pentamethylenecarbamyl chloride and phenylcarbamyl chloride; an alkyl carbamate,
såsom metylkarbamat, metyl-N-metylkarbamat, metyl-N-isopropyl-karbamat, metyl-N,N-dimetylkarbamat og metyl-N,N-(etylen-okso-etylen)karbamat5 et arylkarbamat, såsom fenylkarbamat, fenyl-N-metylkarbamat og fenyl-N-fenyl-karbamat5 et alkyltiolkarbamat, såsom metyl-N-metyltiolkarbamat, etyl-N,N-dimetyltiol-karbamat, og metyl-N-pyridyltiolkarbamat; et aryl-tiolkarbamat, såsom fenyl-N-metyltiolkarbamat og fenyl-N,N-pentametylen-karbamat. Som eksempel på losningsmiddel eller fortynningsmiddel kan nevnes et inert organisk losningsmiddel, såsom etyleter, tetrahydrofuran, dioksan, heksan, kloroform, benzen, toluen, monoklor-, diklor-, og triklorbenzen. Hvis onsket kan ved denne fremgangsmåten en katalysator anvendes. Når forbindelsen (VII) er et karbamylklorid så tilsettes fortrinnsvis et dehydroklorerende middel, såsom dimetylanilin, dietylanilin, N-metylpiperidin, og pyridin. Når forbindelsen (VII) er et karbamat eller tiolkarbamat så kan man anvende .svovelsyre, such as methyl carbamate, methyl-N-methylcarbamate, methyl-N-isopropyl-carbamate, methyl-N,N-dimethylcarbamate and methyl-N,N-(ethylene-oxo-ethylene)carbamate5 an aryl carbamate, such as phenylcarbamate, phenyl-N-methylcarbamate and phenyl-N-phenyl-carbamate5 an alkylthiol carbamate, such as methyl-N-methylthiol carbamate, ethyl-N,N-dimethylthiol carbamate, and methyl-N-pyridylthiol carbamate; an aryl thiolcarbamate, such as phenyl-N-methylthiolcarbamate and phenyl-N,N-pentamethylene carbamate. As an example of a solvent or diluent, mention may be made of an inert organic solvent, such as ethyl ether, tetrahydrofuran, dioxane, hexane, chloroform, benzene, toluene, monochloro-, dichloro- and trichlorobenzene. If desired, a catalyst can be used in this process. When the compound (VII) is a carbamyl chloride, a dehydrochlorinating agent is preferably added, such as dimethylaniline, diethylaniline, N-methylpiperidine and pyridine. When the compound (VII) is a carbamate or thiol carbamate, sulfuric acid can be used,
en organisk syre, f.eks. benzensulfonsyre eller toluensulfonsyre, an organic acid, e.g. benzenesulfonic acid or toluenesulfonic acid,
et ester-utvekslingsmiddel, såsom en organotinf orbindelse, såsom dimetyltinoksyd, dibutyltinoksyd, eller dibutyltin-diacetat, et alkalimetallacetat, såsom natriumacetat, et alkalimetallalkoksyd, såsom natriummetoksyd, natriumetoksyd eller kalium-t-butoksyd, et alkalimetallfenoksyd, såsom natriumfenoksyd. I visse tilfeller, og mens reaksjonen pågår vil azeotrop-destillasjon av under reaksjonen dannet alkohol forbedre utbyttet av produktet (I) betydelig. Fremgangsmåten d) kan utfores ved en temperatur mellom 50 - 200 oC, spesielt 60 - 150°C. Ved utforelsesformen ifolge fremgangsmåte e) får forbindelsen (VIII) reagere med hydrazinderivåtet (IX) i et losningsmiddel eller fortynningsmiddel. Når det gjelder forbindelsen (IX), så kan man anvende hydrazin og monosubstituert hydrazin, f.eks. metylhydrazin, etylhydrazin, fenylhydrazin, semikarbazid, 4-metylsemikarbazid, 4,4-dimetylsemikarbazid, metylsulfonyl-hydrazin, benzensulfonylhydrazin og p-toluensulfonylhydrazin. Som losningsmiddel eller fortynningsmiddel kan man anvende vannholdig metanol, etanol cg propanol. Mengden av hydrazin kan anvendes i overskudd, f.eks. 1-20 mol, spesielt 2-5 mol, av hydrazin pr. mol ftalazon. Reaksjonen kan utfores o o ved en temperatur mellom 50 - 200 C, spesielt ved ca. 100 C. Reaksjonen ifolge fremgangsmåte e) kan gjengis ved hjelp av folgende skjema; an ester exchange agent such as an organotin compound such as dimethyltin oxide, dibutyltin oxide, or dibutyltin diacetate, an alkali metal acetate such as sodium acetate, an alkali metal alkoxide such as sodium methoxide, sodium ethoxide or potassium t-butoxide, an alkali metal phenoxide such as sodium phenoxide. In certain cases, and while the reaction is in progress, azeotrope distillation of the alcohol formed during the reaction will significantly improve the yield of the product (I). Method d) can be carried out at a temperature between 50 - 200°C, especially 60 - 150°C. In the embodiment according to method e), the compound (VIII) is allowed to react with the hydrazine derivative (IX) in a solvent or diluent. As regards the compound (IX), hydrazine and monosubstituted hydrazine can be used, e.g. methylhydrazine, ethylhydrazine, phenylhydrazine, semicarbazide, 4-methylsemicarbazide, 4,4-dimethylsemicarbazide, methylsulfonylhydrazine, benzenesulfonylhydrazine and p-toluenesulfonylhydrazine. Aqueous methanol, ethanol or propanol can be used as a solvent or diluent. The amount of hydrazine can be used in excess, e.g. 1-20 mol, especially 2-5 mol, of hydrazine per moles of phthalazone. The reaction can be carried out o o at a temperature between 50 - 200 C, especially at approx. 100 C. The reaction according to method e) can be reproduced using of the following form;
Uavhengig av hvilken fremgangsmåte som anvendes ved fremstil-lingen kan produktet separeres og renses ved hjelp av konven- Regardless of which method is used in the production, the product can be separated and purified using conventional
sjonelle metoder som senere skal beskrives. tional methods which will be described later.
Oppfinnelsen skal illustreres av folgende eksempler. The invention shall be illustrated by the following examples.
EKSEMPEL 1 EXAMPLE 1
Til en opplosning av 5 g 4-hydroksymetyl-l-ftalazon i ICO ml torket pyridin ble det tilsatt 2 g metylisocyanat. Los-• ni ngen fikk.stå ved romtemperatur .i. en natt, hvorefter den ble oppvarmet 1 time ved 80°c på et vannbad. Pyridinet ble avdestillert under redusert trykk, og resten ble rekrystallisert i metanol, hvorved man fikk 5 g 4-(N-metylkarbamoksy-metyl ) -1-f talazon med smp. 2 30 - 232 C. Produktet hadde; To a solution of 5 g of 4-hydroxymethyl-1-phthalazone in 10 ml of dried pyridine, 2 g of methyl isocyanate were added. The solution was allowed to stand at room temperature. overnight, after which it was heated for 1 hour at 80°C in a water bath. The pyridine was distilled off under reduced pressure, and the residue was recrystallized in methanol, whereby 5 g of 4-(N-methylcarbamoxymethyl)-1-phthalazone with m.p. 2 30 - 232 C. The product had;
folgende formel following formula
EKSEMPEL 2 EXAMPLE 2
Til en opplosning av 3 g 7-brom-4-hydroksymetyl-2-metyl-l-ftalazon i 60 ml torket pyridin ble det tilsatt 1,3 g metylisocyanat. Losningen fikk stå over natten ved romtemperatur og derefter ble den oppvarmet 30 minutter ved 80°C. Lesningen ble fordampet under redusert trykk, og resten ble rekrystallisert i etylacetat-petroleum-eter, hvorved man fikk 3 g 7-brom-4- (N-metylkarbamoksyme.tyl)-2-metyl-l-ftalazon med smp. 181 - 183°C. ' Produktet har" folgende formel: 1.3 g of methyl isocyanate was added to a solution of 3 g of 7-bromo-4-hydroxymethyl-2-methyl-1-phthalazone in 60 ml of dried pyridine. The solution was allowed to stand overnight at room temperature and then it was heated for 30 minutes at 80°C. The reading was evaporated under reduced pressure, and the residue was recrystallized in ethyl acetate-petroleum ether, whereby 3 g of 7-bromo-4-(N-methylcarbamoxymethyl)-2-methyl-1-phthalazone with m.p. 181 - 183°C. The product has the following formula:
EKSEMPEL 3 EXAMPLE 3
Tre gram 4-hydroksymetyl-l-ftalazon og 5 g 3-pyridinkarboksyl-syre ble opplost i 40 ml vanfri pyridin. Reaksjonsblendingens temperatur bie sakte okt til ca. 100°C, og ble holdt 40 minutter ved denne temperatur. Derefter ble losningen oppvarmet ved 125°C under tilbakelop 8 timer. Pyridin ble avdestillert fra reaksjonsblandingen, og den resulterende resten ble rekrystallisert i aceton, hvorved man fikk 2,8 g 4-(N-p-pyridylkarbamoksymetyl)-1-ftalazon med smp. 194 - 196°C. Produktet hadde folgende struktur. Three grams of 4-hydroxymethyl-1-phthalazone and 5 g of 3-pyridinecarboxylic acid were dissolved in 40 ml of anhydrous pyridine. The temperature of the reaction mixture slowly increases to approx. 100°C, and was held for 40 minutes at this temperature. The solution was then heated at 125°C under reflux for 8 hours. Pyridine was distilled off from the reaction mixture, and the resulting residue was recrystallized in acetone, whereby 2.8 g of 4-(N-p-pyridylcarbamoxymethyl)-1-phthalazone with m.p. 194 - 196°C. The product had the following structure.
EKSEMPEL 4 EXAMPLE 4
4 g 4-hydroksymetyl-l-ftalazon, 6 g S-metyl-N-oc-furfuryltiol-karbamat og 3 g trietylamin ble tilsatt til en blandet losning bestående av 40 ml pyridin og 10 mg acetonitril. Til losningen ble det tilsatt en opplosning av 5,2 g solvnitrat i 10 ml acetonitril under avkjoling og omroring. Efter at tilsetningen var fullfort fikk reaksjonsblåndingen stå 24 timer, hvorefter den ble oppvarmet 2 timer til 100 oc. Efter avkjolingen ble reaksjonsblandingen fortynnet med kloroform, og presipitåtet ble filtrert. Den således erholdte resten ble rekrystallisert i etanol og vann, hvorved man fikk 3 g 4- (N-a-furfuryl-karbamoksymetyl)-1-ftalazon med smp. 182 - 184°C. 4 g of 4-hydroxymethyl-1-phthalazone, 6 g of S-methyl-N-oc-furfurylthiol carbamate and 3 g of triethylamine were added to a mixed solution consisting of 40 ml of pyridine and 10 mg of acetonitrile. A solution of 5.2 g of solvent nitrate in 10 ml of acetonitrile was added to the solution while cooling and stirring. After the addition was complete, the reaction mixture was allowed to stand for 24 hours, after which it was heated for 2 hours to 100°C. After cooling, the reaction mixture was diluted with chloroform, and the precipitate was filtered. The residue thus obtained was recrystallized in ethanol and water, whereby 3 g of 4-(N-α-furfurylcarbamoxymethyl)-1-phthalazone with m.p. 182 - 184°C.
EKSEMPEL 5- 27 EXAMPLE 5- 27
På lignende måte som i eksempel 1-4 erholdt man produkter med formel (I) av forbindelser med formel (II) og isocyanat med formel (III) med 70 - 90% utbytte, og som vist i tabell I. In a similar way as in examples 1-4, products of formula (I) were obtained from compounds of formula (II) and isocyanate of formula (III) with 70 - 90% yield, and as shown in table I.
EKSEMPEL 28 EXAMPLE 28
1) Fremstilling av 4- fenoksykarboksyloksymetyl- l- ftalazon Til en opplosning av 5 g 4-hydroksymetyl-l-ftalazon i 25 ml pyridin ble det tilsatt 6 g fenylklorformat ved avkjoling og under omroring. Reaksjonsblandingen fikk stå ved romtemperatur natten over. Reaksjonsblåndingen ble konsentrert under redusert trykk og ble derefter fortynnet med vann. Det resulterende bunnfallet ble filtrert og rekrystallisert fra eter for å gi 6 g av 4-fenoksykarbonyloksymetyl-l-ftalazon som smeltet ved 113 - 114°C. 1) Preparation of 4-phenoxycarboxyloxymethyl-l-phthalazone To a solution of 5 g of 4-hydroxymethyl-l-phthalazone in 25 ml of pyridine, 6 g of phenylchloroformate were added upon cooling and with stirring. The reaction mixture was allowed to stand at room temperature overnight. The reaction mixture was concentrated under reduced pressure and then diluted with water. The resulting precipitate was filtered and recrystallized from ether to give 6 g of 4-phenoxycarbonyloxymethyl-1-phthalazone melting at 113-114°C.
2) Fremstilling av karbamat 2) Preparation of carbamate
Til en opplosning av 6 g 4-fenoksykarbonyloksymetyl-1-ftalazon som foran beskrevet i 100 ml metanol ble det innfort 2 g ammoniakk ved romtemperatur. Losningen fikk stå natten over og derefter ble metanol destillert fra. Resten som således ble erholdt ble rekrystallisert fra metanol for å gi 3,1 g 4-karbamoksymetyl-l-ftalazon som smeltet ved 230 - 232°C. To a solution of 6 g of 4-phenoxycarbonyloxymethyl-1-phthalazone as described above in 100 ml of methanol, 2 g of ammonia were introduced at room temperature. The solution was allowed to stand overnight and then methanol was distilled from it. The residue thus obtained was recrystallized from methanol to give 3.1 g of 4-carbamoxymethyl-1-phthalazone melting at 230-232°C.
EKSEMPEL 2 9 EXAMPLE 2 9
Til en omrort opplosning av metylamin i metanol som var fremstilt fra 4 ml 30%'ig vandig monometylamin og 50 ml metanol ble det tilsatt 2 g 4-fenoksykarbonyloksymetyl-7-metoksy-2-metyl-l-ftalazon fremstilt på samme måte som i eksempel 28,1). Reaksjonsblandingen fikk stå en natt og metanolen ble destillert fra. Resten ble opptatt i kloroform og kloroformekstrak-tet ble vasket i rekkefolge med 5% NaOH-losning og vann. Kloroformen ble destillert fra og resten som således ble erholdt ble rekrystallisert fra metanol-etylacetat for å gi 0,7 g 4- (N-metyl-karbamoksymetyl)-7-metoksy-2-metyl-l-ftalazon med smeltepunkt på 171 - 173°C. To a stirred solution of methylamine in methanol which was prepared from 4 ml of 30% aqueous monomethylamine and 50 ml of methanol was added 2 g of 4-phenoxycarbonyloxymethyl-7-methoxy-2-methyl-1-phthalazone prepared in the same way as in example 28,1). The reaction mixture was allowed to stand overnight and the methanol was distilled off. The residue was taken up in chloroform and the chloroform extract was washed successively with 5% NaOH solution and water. The chloroform was distilled off and the residue thus obtained was recrystallized from methanol-ethyl acetate to give 0.7 g of 4-(N-methyl-carbamoxymethyl)-7-methoxy-2-methyl-1-phthalazone, mp 171 - 173 °C.
EKSEMPEL 30 EXAMPLE 30
4 g 4-metyltiokarbonyloksymetyl-l-ftalazon fremstilt fra 4-hydroksymetyl-l-ftalazon og metylklortiol-formal på sammemåte som i eksempel 28, 1), ble opplost i 20 ml metanol. Til opplosningen ble det tilsatt 1 g dimetylamin under omroring. Reaksjonsblåndingen fikk stå ved romtemperatur i 3 timer og ble derefter torket under redusert trykk. Resten ble rekrystallisert fra etylacetat-petroleumeter for å gi 0,6 g 4-(N,N-dimetyl-karbamoksymetyl)-1-ftalazon som smelter ved 174 - 176°C. 4 g of 4-methylthiocarbonyloxymethyl-1-phthalazone prepared from 4-hydroxymethyl-1-phthalazone and methylchlorothiol-formal in the same way as in example 28, 1), was dissolved in 20 ml of methanol. 1 g of dimethylamine was added to the solution while stirring. The reaction mixture was allowed to stand at room temperature for 3 hours and was then dried under reduced pressure. The residue was recrystallized from ethyl acetate-petroleum ether to give 0.6 g of 4-(N,N-dimethylcarbamoxymethyl)-1-phthalazone melting at 174-176°C.
EKSEMPEL 31- 5 EXAMPLE 31-5
På samme måte som i eksempel 28-30 ble produktene med formel (I) erholdt fra utgangsforbindelsene som er representert med formel (IV) og ammoniakk eller aminene som er representert ved formel (V) i et 70 - 90%'ig utbytte, som vist i tabell II. In the same way as in examples 28-30, the products of formula (I) were obtained from the starting compounds represented by formula (IV) and ammonia or the amines represented by formula (V) in a 70-90% yield, which shown in Table II.
EKSEMPEL 51 EXAMPLE 51
Til en omrort opplosning av 3,4 g 4-hydroksymetyl-l-ftalazon og 3,2 g dimetylanilin i 100 ml torket toluen ble det tilsatt dråpevis en opplosning av 2,2 g fosgen i 20 ml toluen ved en temperatur på 0 - 5°C. Efter avsluttet tilsetning ble reaksjonsblandingen omrort i 3 timer ved 0 - 5 oC og 3 timer ved ca. To a stirred solution of 3.4 g of 4-hydroxymethyl-1-phthalazone and 3.2 g of dimethylaniline in 100 ml of dried toluene, a solution of 2.2 g of phosgene in 20 ml of toluene was added dropwise at a temperature of 0 - 5 °C. After completion of the addition, the reaction mixture was stirred for 3 hours at 0 - 5 oC and 3 hours at approx.
10°C. Mens man holdt temperaturen til blandingen under 10°C 10°C. While keeping the temperature of the mixture below 10°C
ble en ytterligere mengde av ammoniakk innfort. Blandingen ble holdt under 10°C og fikk så stå til henstand ved romtemperatur i 3 timer. Blandingen ble vasket med vann, toluen-sjiktet ble separert og vannfasen ble ekstrahert med etylacetat. Den forente toluen og etylacetat-losningen ble torket og destillert under redusert trykk. Resten som således ble erholdt ble rekrystallisert fra metanol for å gi 4-karbamoksymetyl-l-ftalazon som smeltet ved 2 30 - 2 32 oC. A further amount of ammonia was introduced. The mixture was kept below 10°C and then allowed to stand at room temperature for 3 hours. The mixture was washed with water, the toluene layer was separated and the aqueous phase was extracted with ethyl acetate. The combined toluene and ethyl acetate solution was dried and distilled under reduced pressure. The residue thus obtained was recrystallized from methanol to give 4-carbamoxymethyl-1-phthalazone which melted at 2 30 - 2 32 oC.
EKSEMPEL 52 EXAMPLE 52
En opplosning av 9,2 g 7-klor-4-hydroksymetyl-2-metyl-l-ftalazon og 7 g dimetylanilin i 300 ml torket toluen ble avkjolt til -5 - 0°C. Til opplosningen ble det tilfort 5,5 g fosgen under omroring ved -5 - 0°C. Efter tilsetningen av fosgen var avsluttet ble blandingen omrort ved 0 - 5 QC i 5 timer, og derefter ble 5 ml 30%'ig vandig metylamin tilsatt ved 0 - 5°c under omroring. Reaksjonsblandingen ble omrort i en time og sto derefter til henstand ved romtemperatur i 3 timer. Blandingen ble vasket med vann og toluenlosningen ble torket og destillert fra. Resten ble rekrystallisert fra etylacetat for å gi 6,5 g 7-klor-4-(N-metyl-karbamoksymetyl)-2-metyl-l-ftalazon som smelter ved 148 - 149 oC. A solution of 9.2 g of 7-chloro-4-hydroxymethyl-2-methyl-1-phthalazone and 7 g of dimethylaniline in 300 ml of dried toluene was cooled to -5-0°C. 5.5 g of phosgene were added to the solution with stirring at -5 - 0°C. After the addition of phosgene was finished, the mixture was stirred at 0-5°C for 5 hours, and then 5 ml of 30% aqueous methylamine was added at 0-5°C with stirring. The reaction mixture was stirred for one hour and then allowed to stand at room temperature for 3 hours. The mixture was washed with water and the toluene solution was dried and distilled off. The residue was recrystallized from ethyl acetate to give 6.5 g of 7-chloro-4-(N-methyl-carbamoxymethyl)-2-methyl-1-phthalazone melting at 148-149 oC.
Analyse av elementene: Analysis of the elements:
EKSEMPLENE 53 - 5 9 .. EXAMPLES 53 - 5 9 ..
På lignende måte som i eksempel 51 - 52 ble produktene med formel (I) erholdt fra utgangsforbindelsene som er representert med formel (II) og aminene som er representert med formel (V) In a similar manner to examples 51 - 52, the products of formula (I) were obtained from the starting compounds represented by formula (II) and the amines represented by formula (V)
i et 40 - 60%'ig utbytte som vist i tabell III. in a 40 - 60% yield as shown in table III.
EKSEMPEL 60 EXAMPLE 60
En blanding av 4 g 7-klor-4-hydroksymetyl-2-metyl-l-ftalazon, A mixture of 4 g of 7-chloro-4-hydroxymethyl-2-methyl-1-phthalazone,
3 g dimetylanilin, 2 g metylkarbamylklorid og 40 ml absolutt etyleter ble tilbakelopsbehandlet i 5 timer. Reaksjonsblandingen ble vasket i rekkefolge med vann, 3%'ig HC1 og vann. Etyleteren ble torket og destillert fra. Resten ble rekrystallisert fra etylacetat for å gi 2,2 g av 7-klor-4- (N-metyl-karbamoksymetyl)-2-metyl-l-ftalazon som smelter ved 148 - 149°C. 3 g of dimethylaniline, 2 g of methylcarbamyl chloride and 40 ml of absolute ethyl ether were refluxed for 5 hours. The reaction mixture was washed sequentially with water, 3% HCl and water. The ethyl ether was dried and distilled from. The residue was recrystallized from ethyl acetate to give 2.2 g of 7-chloro-4-(N-methyl-carbamoxymethyl)-2-methyl-1-phthalazone melting at 148-149°C.
EKSEMPEL 61 EXAMPLE 61
Til en opplosning av 3 g 4-hydroksymetyl-2-me.tyl-l-ftalazon og 1,3 g metyl-N-metylkarbamat i 100 ml n-heptan ble det tilsatt 0,3 g natrium-metoksyd. Mens reaksjonsblandingen kokte forsiktig ble heptan gradevis destillert fra. Destillatet ble innfort i en Dean-Stark-separator, gjennom hvilken metanol som var separert ble trukket ut og heptan ble helt tilbake i reaksjonsflasken. Efter dannelsen av metanol var avtatt, To a solution of 3 g of 4-hydroxymethyl-2-methyl-1-phthalazone and 1.3 g of methyl-N-methylcarbamate in 100 ml of n-heptane, 0.3 g of sodium methoxide was added. While the reaction mixture was gently boiling, heptane was gradually distilled off. The distillate was introduced into a Dean-Stark separator, through which methanol that had been separated was withdrawn and heptane was returned to the reaction flask. After the formation of methanol had subsided,
ble volumet av reaksjonsblandingen konsentrert til ca. halv-parten av det opprinnelige volumet ved destillering. Resten ble fortynnet", med isvann og heptan ble separert og vannsjiktet ble ekstrahert med eter. Heptanlbsningen og eterekstraktet ble forenet og losningen ble destillert fra. Resten som var oppnådd the volume of the reaction mixture was concentrated to approx. half of the original volume when distilled. The residue was diluted with ice water and heptane was separated and the aqueous layer was extracted with ether. The heptane solution and ether extract were combined and the solution was distilled from. The residue obtained
ble rekrystallisert fra etylacetat-petroleter for å gi 1,7 g 4-(N-metyl-karbamoksymetyl)-2-metyl-l-ftalazon som smelter ved 115 - 116°C. was recrystallized from ethyl acetate-petroleum ether to give 1.7 g of 4-(N-methyl-carbamoxymethyl)-2-methyl-1-phthalazone melting at 115-116°C.
EKSEMPEL 62 EXAMPLE 62
En blanding av 3 g 4-hydroksymetyl-7-metoksy-l-ftalazon, 10 g fenyl-N-metylkarbamat, 0,5 g natriumacetat og 20 ml triklorbenzen ble oppvarmet i 5 timer ved en temperatur på 80 - 90°C A mixture of 3 g of 4-hydroxymethyl-7-methoxy-1-phthalazone, 10 g of phenyl-N-methyl carbamate, 0.5 g of sodium acetate and 20 ml of trichlorobenzene was heated for 5 hours at a temperature of 80 - 90°C
i et vannbad. Lavtkokende substanser ble destillert fra under redusert trykk, den resulterende resten ble ekstrahert med kloroform. Kloroformldsningen ble vasket med vann og losnings-midl ene ble destillert fra. Resten ble rekrystallisert fra metanol for å gi 2,3 g 4-(N-metyl-karbamoksymetyl)-7-metoksy-l-ftalazon som smelter ved 219 - 220°C. in a water bath. Low-boiling substances were distilled from under reduced pressure, the resulting residue was extracted with chloroform. The chloroform was washed with water and the solvents were distilled off. The residue was recrystallized from methanol to give 2.3 g of 4-(N-methyl-carbamoxymethyl)-7-methoxy-1-phthalazone melting at 219-220°C.
EKSEMPEL 63 EXAMPLE 63
En blanding av 1 g 7-klor-4-hydroksymetyl-l-ftalazon, 3 g fenyltiolkarbamat, 0,2 g natriumacetat og 15 ml dioksan ble oppvarmet i 3 timer ved en temperatur pa 80 - 90 oc. Ved destillering i vakuum ble lavtkokende substanser eliminert. A mixture of 1 g of 7-chloro-4-hydroxymethyl-1-phthalazone, 3 g of phenylthiocarbamate, 0.2 g of sodium acetate and 15 ml of dioxane was heated for 3 hours at a temperature of 80-90°C. By distillation in vacuum, low-boiling substances were eliminated.
Den resulterende resten ble ekstrahert med kloroform og kloro-formekstraktet ble vasket i rekkefolge med 5% NaOH-losning og vann. Kloroform ble destillert fra og resten ble rekrystallisert fra metanol for å gi 0,5 g 7-klor-4-karbamoksymetyl-l-ftalazon som smelter ved 243 - 245°0. The resulting residue was extracted with chloroform and the chloroform extract was washed sequentially with 5% NaOH solution and water. Chloroform was distilled from and the residue was recrystallized from methanol to give 0.5 g of 7-chloro-4-carbamoxymethyl-1-phthalazone melting at 243-245°C.
Analyse av elementer: Analysis of elements:
EKSEMPEL 64 EXAMPLE 64
1) En opplosning av 3 g tu- (N-metyl-karbamoksy)-2-karbamoylaceto-fenon og 4 ml 85%'ig hydrazinhydrat i 100 ml metanol ble tilbakelopsbehandlet i 3 timer. Reaksjonsblandingen ble konsentrert under redusert trykk og avkjolt til romtemperatur. 1) A solution of 3 g of tu-(N-methyl-carbamoxy)-2-carbamoylaceto-phenone and 4 ml of 85% hydrazine hydrate in 100 ml of methanol was refluxed for 3 hours. The reaction mixture was concentrated under reduced pressure and cooled to room temperature.
De utfelte krystallende ble filtrert og rekrystallisert fra metanol for å gi 2,5 g 4-(N=metyl-karbamoksymetyl)-1-ftalazon som smelter ved 230 - 232°C. 2) w- (N-metyl-karbamoksy)-2-karbamoylacetofenon, utgangsfor-bindelsen i 1), ble fremstilt ved folgende fremgangsmåte. 2 g 4-okso-3,4-dihydroisokumarin (smp. 147 - 148°C) ble tilsatt porsjonsvis i 60 ml konsentrert ammoniakk under omroring. Blandingen ble omrort ytterligere 5 timer ved romtemperatur og derefter torket under redusert trykk ved under 50°C. Resten ble rekrystallisert fra aceton for å gi 1,6 g cu-oksy-2-karbamoylacetof enon som smelter ved 151 - 153°C. 1 g av UJ-oksy-2-karbamoylacetofenon som ovenfor fremstilt og 0,4 g metylisocyanat ble opplost i 20 ml pyridin. Reaksjonsblandingen fikk stå natten over og ble derefter oppvarmet til 40°C i en time. Efter av pyridin var destillert fra ble resten rekrystallisert fra metanol-etylacetat for å gi 0,7 g oi-(N-metyl-karbamoksy)-2-karbamoylacetofenon med smp. 180 - 182°C. The precipitated crystals were filtered and recrystallized from methanol to give 2.5 g of 4-(N=methylcarbamoxymethyl)-1-phthalazone melting at 230-232°C. 2) w-(N-methyl-carbamoxy)-2-carbamoylacetophenone, the starting compound in 1), was prepared by the following method. 2 g of 4-oxo-3,4-dihydroisocoumarin (m.p. 147 - 148°C) was added portionwise to 60 ml of concentrated ammonia while stirring. The mixture was stirred for a further 5 hours at room temperature and then dried under reduced pressure at below 50°C. The residue was recrystallized from acetone to give 1.6 g of Cu-oxy-2-carbamoylacetof enone melting at 151-153°C. 1 g of UJ-oxy-2-carbamoylacetophenone as prepared above and 0.4 g of methyl isocyanate were dissolved in 20 ml of pyridine. The reaction mixture was allowed to stand overnight and then heated to 40°C for one hour. After the pyridine was distilled off, the residue was recrystallized from methanol-ethyl acetate to give 0.7 g of o-(N-methyl-carbamoxy)-2-carbamoylacetophenone with m.p. 180 - 182°C.
EKSEMPEL 65 EXAMPLE 65
En opplosning av 2 g oi- (N-metyl-karbamoksy)-2-karbamoyl-acetof enon som beskrevet i eksempel 64, 2) og 5 ml fenylhydrazin i 20 ml etanol ble tilbakelopsbehandlet i 3 timer i et vannbad. Losningsmidlet ble destillert fra og resten ble rekrystallisert fra etanol-n-heksan for å gi 3 g 4- (N-metyl-karbamoksymetyl)-2-fenyl-l-ftalazon som smelter ved 136 - 138°C. A solution of 2 g of o-(N-methyl-carbamoxy)-2-carbamoyl-acetophenone as described in Example 64, 2) and 5 ml of phenylhydrazine in 20 ml of ethanol was refluxed for 3 hours in a water bath. The solvent was distilled off and the residue was recrystallized from ethanol-n-hexane to give 3 g of 4-(N-methyl-carbamoxymethyl)-2-phenyl-1-phthalazone melting at 136-138°C.
EKSEMPEL 66- 70 EXAMPLE 66-70
På samme måte som i eksempel 1 fra reaksjonen av 4-hydroksymetyl-l-f talazon og B-dimetylaminoéylisocyanat ble 4-[N- (p-dimetylaminoetyl)-karbamoksymetyl]-1-ftalazon med smp. 148 - 150°C erholdt (rekrystallisert fra etylacetat) erholdt i 75%'ig utbytte, hvj.s struktur vises nedenfor. In the same way as in example 1 from the reaction of 4-hydroxymethyl-1-phthalazone and B-dimethylaminoethyl isocyanate, 4-[N-(p-dimethylaminoethyl)-carbamoxymethyl]-1-phthalazone with m.p. 148 - 150°C obtained (recrystallized from ethyl acetate) obtained in 75% yield, whose structure is shown below.
På lignende måte ble 4-[n- ((3-dietylaminoetyl) -karbamoksymetyl] -1-ftalazon som smelter ved 116 - 120°C (rekrystallisert fr ei etyleter), 4-[N- (y-dimetylaminopropyl)-karbamoksymetyl]-2-fenyl-1-ftalazon som smelter ved 159 - 160°C (rekrystallisert fra etylacetat), 7-brom-4-[N-((3-dimetylaminoetyl)-karbamoksymetyl] -1-ftalazon som smelter ved 184 - 186°C (rekrystallisert fra etylacetat) , og 4-[N-(y-dimetylaminopropyl)-karbamoksymetyl]-2-metyl-l-ftalazon-oksalat med smeltepunkt 158 - 169 oC (rekrystallisert fra etanol) erholdt. Similarly, 4-[n-((3-diethylaminoethyl)-carbamoxymethyl]-1-phthalazone melting at 116 - 120°C (recrystallized from an ethyl ether), 4-[N-(γ-dimethylaminopropyl)-carbamoxymethyl] -2-phenyl-1-phthalazone melting at 159 - 160°C (recrystallized from ethyl acetate), 7-bromo-4-[N-((3-dimethylaminoethyl)-carbamoxymethyl] -1-phthalazone melting at 184 - 186 °C (recrystallized from ethyl acetate), and 4-[N-(γ-dimethylaminopropyl)-carbamoxymethyl]-2-methyl-1-phthalazone-oxalate with melting point 158 - 169 oC (recrystallized from ethanol) obtained.
EKSEMPLENE 71 - 78 EXAMPLES 71 - 78
På samme måte som i eksempel 28 ble reaksjons-resultatet av 4-fenoksykarbonyloksymetyl-l-ftalazon og N-metylpiperazin, 4-[N,N- (etylen-metylimino-etylen)-karbamoksymetyl]-1-ftalazon som smelter ved 152 - 154°C (rekrystallisert fra metanol) erholdt i 80%'ig utbytte, hvis struktur vises nedenfor. In the same way as in Example 28, the reaction result of 4-phenoxycarbonyloxymethyl-1-phthalazone and N-methylpiperazine was 4-[N,N-(ethylene-methylimino-ethylene)-carbamoxymethyl]-1-phthalazone which melts at 152 - 154°C (recrystallized from methanol) obtained in 80% yield, the structure of which is shown below.
På lignende måte ble 4-[N- (y-dietylaminopropyl)-karbamoksymetyl]-1-ftalazon med smp. 133 - 135°C (rekrystallisert fra etylacetat/petroleter), 4-[N-(y-dietylaminopropyl)-karbamoksymetyl]-7-metoksy-l-ftalazon som smelter ved 162 - 163°C. (rekrystal- In a similar manner, 4-[N-(γ-diethylaminopropyl)-carbamoxymethyl]-1-phthalazone with m.p. 133 - 135°C (recrystallized from ethyl acetate/petroleum ether), 4-[N-(γ-diethylaminopropyl)-carbamoxymethyl]-7-methoxy-1-phthalazone melting at 162 - 163°C. (recrystallized
lisert fra etylacetat) , 4-[N-((3-dimetylaminoetyl)-karbamoksymetyl]-7-metoksy-l-f talazon som smelter ved 159 - 160°C. lysed from ethyl acetate), 4-[N-((3-dimethylaminoethyl)-carbamoxymethyl]-7-methoxy-1-phthalazone melting at 159 - 160°C.
(rekrystallisert fra etylacetat), 6,7-dimetyl-4-[N-(p-dimetylaminoetyl) -karbamoksymetyl] -1-f talazon som smelter ved 172 - 173°C. (recrystallized from ethyl acetate), 6,7-dimethyl-4-[N-(p-dimethylaminoethyl)-carbamoxymethyl]-1-phthalazone melting at 172-173°C.
(rekrystallisert fra etylacetat), 6,7-dimetyl-4-[N,N-(etylen-metylimino-etylen)-karbamoksymetyl]-1-f talazon som smelter ved 208 - 210°C. (rekrystallisert fra etanol/n-heksan), 7-klor-4-[n,N- (etylen-metylimino-etylen)-karbamoksymetyl]-1-ftalazon som smelter ved 171 - 172°C. (rekrystallisert fra etanol/n- (recrystallized from ethyl acetate), 6,7-dimethyl-4-[N,N-(ethylene-methylimino-ethylene)-carbamoxymethyl]-1-phthalazone melting at 208 - 210°C. (recrystallized from ethanol/n-hexane), 7-chloro-4-[n,N-(ethylene-methylimino-ethylene)-carbamoxymethyl]-1-phthalazone melting at 171 - 172°C. (recrystallized from ethanol/n-
heksan) , og 5-acetylamino-4-[N,N-(etylenmetyliminoetylen)-karbamoksymetyl]-1-ftalazon som smelter ved 243 - 245°C (rekrystallisert fra etanol/n-heksan) erholdt. hexane), and 5-acetylamino-4-[N,N-(ethylenemethyliminoethylene)-carbamoxymethyl]-1-phthalazone melting at 243 - 245°C (recrystallized from ethanol/n-hexane) is obtained.
EKSEMPEL 79- 80 EXAMPLE 79-80
På samme måte som i eksempel 52 ble fra reaksjonen av 4-hydroksymetyl-2-metyl-l-ftalazon og f3-dimetylaminoetylamin, 4-[N- ((3-dimetylaminoetyl) -karbamoksymetyl]-2-metyl-l-ftalazo.n-oksalat som smelter ved 193 - 195°C (rekrystallisert fra etanol) erholdt i 54%'ig utbytte. På lignende måte ble 4-[N- ((3-dimetylaminoetyl) - karbamoksymetyl]-2-fenyl-l-ftalazon som smelter ved 155 - 157°C (rekrystallisert fra etylacetat) erholdt. In the same manner as in Example 52, from the reaction of 4-hydroxymethyl-2-methyl-1-phthalazone and 3-dimethylaminoethylamine, 4-[N-((3-dimethylaminoethyl)-carbamoxymethyl]-2-methyl-1-phthalazo was obtained. n-oxalate melting at 193 - 195°C (recrystallized from ethanol) was obtained in 54% yield.In a similar manner, 4-[N-((3-dimethylaminoethyl)-carbamoxymethyl]-2-phenyl-1-phthalazone which melts at 155 - 157°C (recrystallized from ethyl acetate) is obtained.
Biologisk effekt Biological effect
Efter oral administrasjon av 10 mg/kg av forbindelsen ifolge nærværende oppfinnelse til en kanin ble intensiteten av blodplate-aggragasjonen forårsaket av adenisindifosfat målt ved Borns metode (Born, J. Physiol. 162, 67 (1962), se også 0'Brien. After oral administration of 10 mg/kg of the compound of the present invention to a rabbit, the intensity of platelet aggregation caused by adenine diphosphate was measured by Born's method (Born, J. Physiol. 162, 67 (1962), see also O'Brien.
J. Clin. Path. 15, 452 (1962), Lancet, 1, 779 (1968). J. Clin. Path. 15, 452 (1962), Lancet, 1, 779 (1968).
En kanin ble injisert med adrenalin (Lug/kg) 3 timer efter A rabbit was injected with adrenaline (Lug/kg) 3 hours later
oral administrasjon av proven. 5 minutter efter injeksjonen ble 4,5 ml blod tatt fra halspulsåren og derefter fortynnet med 0,5 ml av en 3,8%'ig losning av natriumcitrat. Efter sentrifugering av blodet ved 1000 g i 30 minutter ble 0,9 ml av alikvotene tatt fra det overste sjiktet. Alikvotene ble oral administration of the test. 5 minutes after the injection, 4.5 ml of blood was taken from the carotid artery and then diluted with 0.5 ml of a 3.8% solution of sodium citrate. After centrifugation of the blood at 1000 g for 30 minutes, 0.9 ml of the aliquots were taken from the top layer. The aliquots were
-5 -4 -5 -4
hver tilsatt 0,1 ml av 3 x 10 molare og 10 molare los- each added 0.1 ml of 3 x 10 molar and 10 molar los-
ninger av adenosin-difosfat. Folgelig var de molare konsentrasjoner nings of adenosine diphosphate. Consequently, they were molar concentrations
— 6 — 5 — 6 — 5
av ADP i serumet hhv. 3 x IO og 10 . Intensiteten av blodplate-aggregasjonen ble målt ved å anvende et blodplate-aggregasjons-meter (Model 169, Evans Elect. Ltd. England). Intensitenene av den ADP-forårsakede blodplate-aggregasjonen vises prosentuelt i forhold til den pre-injiserte mengde. of ADP in the serum or 3 x IO and 10 . The intensity of platelet aggregation was measured using a platelet aggregation meter (Model 169, Evans Elect. Ltd. England). The intensities of the ADP-induced platelet aggregation are shown as a percentage of the pre-injected amount.
Som vist i tabell IV, så viser forbindelser ifolge nærværende oppfinnelse lavere verdier ved ADP-forårsaket blodplate-aggrega-sjon, og folgelig forebygges en okning av koaguleringsevnen og thromboserisikoen. As shown in table IV, compounds according to the present invention show lower values for ADP-induced platelet aggregation, and consequently an increase in the coagulation ability and the risk of thrombosis is prevented.
Claims (1)
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT148072T | 1935-11-11 | ||
JP836871A JPS5017072B1 (en) | 1971-02-23 | 1971-02-23 | |
JP983671A JPS5010868B1 (en) | 1971-02-27 | 1971-02-27 | |
JP983571A JPS5010867B1 (en) | 1971-02-27 | 1971-02-27 | |
JP983771A JPS5010869B1 (en) | 1971-02-27 | 1971-02-27 | |
JP5864471A JPS5030623B2 (en) | 1971-08-05 | 1971-08-05 | |
JP5990471A JPS5030624B2 (en) | 1971-08-10 | 1971-08-10 | |
JP5990571A JPS5030625B2 (en) | 1971-08-10 | 1971-08-10 | |
JP46061636A JPS5030626B2 (en) | 1971-08-16 | 1971-08-16 | |
JP6334071A JPS5030627B2 (en) | 1971-08-21 | 1971-08-21 | |
JP6894071A JPS5030628B2 (en) | 1971-09-08 | 1971-09-08 | |
JP6925071A JPS5030629B2 (en) | 1971-09-09 | 1971-09-09 | |
AT443873A AT318636B (en) | 1935-11-11 | 1972-02-23 | Process for the preparation of new 4-carbamoxymethyl-1-phthalazone derivatives and their acid addition salts |
Publications (2)
Publication Number | Publication Date |
---|---|
NO134299B true NO134299B (en) | 1976-06-08 |
NO134299C NO134299C (en) | 1976-09-15 |
Family
ID=27583880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO534/72A NO134299C (en) | 1935-11-11 | 1972-02-22 |
Country Status (15)
Country | Link |
---|---|
AR (3) | AR199548A1 (en) |
AU (1) | AU462374B2 (en) |
BE (1) | BE779626A (en) |
CA (1) | CA1004673A (en) |
CH (1) | CH575932A5 (en) |
DE (1) | DE2208325A1 (en) |
DK (1) | DK130642B (en) |
FI (1) | FI52576C (en) |
FR (1) | FR2126321B1 (en) |
GB (1) | GB1365806A (en) |
IE (1) | IE36226B1 (en) |
LU (1) | LU64815A1 (en) |
NL (1) | NL7202373A (en) |
NO (1) | NO134299C (en) |
SE (1) | SE386167B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4333761A1 (en) * | 1993-10-04 | 1995-04-06 | Luitpold Pharma Gmbh | Heterocyclic carbamates, process for their preparation and pharmaceuticals |
-
1972
- 1972-02-08 IE IE155/72A patent/IE36226B1/en unknown
- 1972-02-10 SE SE7201580A patent/SE386167B/en unknown
- 1972-02-17 AR AR240576A patent/AR199548A1/en active
- 1972-02-17 AU AU39099/72A patent/AU462374B2/en not_active Expired
- 1972-02-21 LU LU64815D patent/LU64815A1/xx unknown
- 1972-02-21 BE BE779626A patent/BE779626A/en not_active IP Right Cessation
- 1972-02-22 CA CA135,307A patent/CA1004673A/en not_active Expired
- 1972-02-22 DE DE19722208325 patent/DE2208325A1/de active Pending
- 1972-02-22 GB GB811672A patent/GB1365806A/en not_active Expired
- 1972-02-22 DK DK82272AA patent/DK130642B/en not_active IP Right Cessation
- 1972-02-22 NO NO534/72A patent/NO134299C/no unknown
- 1972-02-22 FI FI720476A patent/FI52576C/en active
- 1972-02-23 NL NL7202373A patent/NL7202373A/xx not_active Application Discontinuation
- 1972-02-23 CH CH258872A patent/CH575932A5/xx not_active IP Right Cessation
- 1972-02-23 FR FR7206037A patent/FR2126321B1/fr not_active Expired
- 1972-12-26 AR AR245832A patent/AR199653A1/en active
- 1972-12-26 AR AR245833A patent/AR199654A1/en active
Also Published As
Publication number | Publication date |
---|---|
FR2126321B1 (en) | 1975-08-01 |
AR199548A1 (en) | 1974-09-13 |
IE36226L (en) | 1972-08-23 |
DK130642C (en) | 1975-08-18 |
AR199654A1 (en) | 1974-09-23 |
GB1365806A (en) | 1974-09-04 |
AU3909972A (en) | 1973-08-23 |
LU64815A1 (en) | 1972-07-05 |
CA1004673A (en) | 1977-02-01 |
DE2208325A1 (en) | 1972-10-12 |
FI52576B (en) | 1977-06-30 |
AU462374B2 (en) | 1975-06-26 |
DK130642B (en) | 1975-03-17 |
IE36226B1 (en) | 1976-09-15 |
NO134299C (en) | 1976-09-15 |
FR2126321A1 (en) | 1972-10-06 |
AR199653A1 (en) | 1974-09-23 |
SE386167B (en) | 1976-08-02 |
CH575932A5 (en) | 1976-05-31 |
NL7202373A (en) | 1972-08-25 |
BE779626A (en) | 1972-06-16 |
FI52576C (en) | 1977-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU744059B2 (en) | CCR-3 receptor antagonists | |
CA2327253C (en) | Sulfonamide-containing indole compounds | |
US5618945A (en) | Process for the sulfinylation of heterocyclic compounds | |
PT98011B (en) | PROCESS FOR THE PREPARATION OF UREAL PYRAZOLOPYRYIDINONES AS ANTI-GANGING AGENTS | |
US5843947A (en) | N-pyridyl carboxamides and derivatives | |
US4617401A (en) | 8-substituted pyrrolizidine and quaternary ammonium salts thereof | |
US4847289A (en) | Thiophene sulfonamide antiglaucoma agents | |
PT93717A (en) | PROCESS FOR THE PREPARATION OF THIOUREIA / CYANOGUANIDINE DERIVATIVES | |
DK157079B (en) | METHOD FOR PREPARING 7BETA-AMINO-3-CEPHEM-3-OL-4-CARBOXYLIC ACID COMPOUNDS OR SALTS THEREOF | |
EP1446399B1 (en) | Piperazine derivatives having sst1 antagonistic activity | |
Foks et al. | Synthesis and tuberculostatic activity of new benzimidazole derivatives | |
US4183856A (en) | Process for the production of urea derivatives | |
CA2690079C (en) | Sulfonyl-quinoline derivatives | |
NO134299B (en) | ||
WO1998040378A1 (en) | Process for the preparation of 2-[[(2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose | |
NO770161L (en) | THIAZOLIDINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION. | |
JP2790926B2 (en) | Sulfonamide derivative | |
EP0252640B1 (en) | Alkanesulfonamides as antiglaucoma agents | |
DE9290049U1 (en) | 4-aryl-3- (heteroarylureido) quinoline derivatives | |
US3636041A (en) | 4 5-dihydro-7h-thieno(2 3-c)thiopyrans | |
SE452156B (en) | NEW INDOLINONES, PROCEDURES FOR THE PREPARATION OF THESE AND MEDICINAL AGENTS FOR TROMBOEMBOLIC DISEASES, ATERIOSCLEROSIS AND FOR METASTAS PROPHYLAX | |
JPS63188665A (en) | 5-hydroxyindole-3-carboxylic acid ester compound | |
US3833579A (en) | 4-carbamoyl phthalazones | |
DE3605743A1 (en) | 1,6-NAPHTHYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF | |
US3176015A (en) | Phentfflazine derivatives |